Catalyst Wire Dossier Catalyst Wire Dossier

KemSu

ketamine hydrochloride; sufentanil citrate · Proveca Pharma Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KemSu, covering 2026-08-13 to 2026-08-13. Get the full timeline:

Most recent: EMA Opinion under re-examination: KemSu (ketamine hydrochloride;sufentanil citrate) — Proveca Pharma Limited

See pricing